Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases

Valerie Dehondt, PharmD, and Lies Lahousse, PharmD, PhD, join CHEST® Journal Podcast Moderator Gretchen Winter, MD, to discuss their research into the association between long-term proton pump inhibitor use and exacerbation risk in patients with chronic obstructive airway diseases. DOI: 10.1016/j.chest.2026.01.002 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

You can listen to Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases online on Radio and Podcast. Open the player on this page to stream the available audio.

Exacerbation Risk by Chronic Proton Pump Inhibitor Use in Obstructive Lung Diseases is an episode from CHEST Journal Podcasts by American College of Chest Physicians.

This episode is 13:20 long.

This episode was published on May 1, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from CHEST Journal Podcasts when more episodes are available from the podcast feed.